CLS HOLDINGS USA, INC. (OTCMKTS:CLSH) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.03Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

Effective July 18, 2017, we adopted a Certificate of Designation, which amended our Articles of Incorporation, to the power of our Board of Directors to designate classes of our preferred stock and to establish the rights and preferences of such newly designated preferred stock. Effective July 18, 2017, our Board of Directors authorized the issuance of up to 650,000 shares of Series A Convertible Preferred Stock. The Board had not yet authorized the issuance of any such stock.

Each share of Series A Convertible Preferred Stock has a stated value of $.70 per share and a liquidation preference that is senior to our common stock equal to such amount. In addition, each share of Series A Convertible Preferred Stock is convertible into 10 shares of common stock. The Series A Convertible Preferred Stock is non-voting stock, does not accrue dividends and does not have any other terms that are senior to our common stock.

Item 9.01Financial Statements and Exhibits

(d)Exhibits.

CLS Holdings USA, Inc. Exhibit
EX-3.1 2 ex3-1.htm EX-3.1 EXHIBIT 3.1         BARBARA K. CEGAVSKE Secretary of State 202 North Carson Street Carson City,…
To view the full exhibit click here

About CLS HOLDINGS USA, INC. (OTCMKTS:CLSH)

CLS Holdings USA, Inc., is engaged in developing a method of extracting cannabinoids from cannabis plants and converting the resulting cannabinoid extracts into concentrates. The Company’s concentrates include oils, waxes, edibles and shatter. These concentrates may be ingested in various ways, including through vaporization through electronic cigarettes (e-cigarettes), and used for a range of pharmaceutical and other purposes. The Company intends to monetize extraction method through the licensing of its methods and processes to others, as in the Colorado Arrangement; the processing of cannabis for others, and the purchase of cannabis and the processing and sale of cannabis-related products. The Company’s products and services include Licensing Operations, Processing Revenue, Processing Facilities and Sale of Products and Brand Creation. As of May 31, 2016, the Company had not generated any revenues.